학술논문

Efficacy and safety of second-line therapy of docetaxel plus ramucirumab after first-line platinum-based chemotherapy plus immune checkpoint inhibitors in non-small cell lung cancer (SCORPION): a multicenter, open-label, single-arm, phase 2 trial
Document Type
Article
Source
In eClinicalMedicine December 2023 66
Subject
Language
ISSN
2589-5370